ÂÜÀòÂÒÂ×

Paul Laquerre is currently serving as the Chief Financial Officer at Balt, a neurointerventional company with a complete portfolio. Prior to their current role, Paul held the same position at AgNovos Bioscience, a company developing treatments for osteoporosis, and at Seropeutics, LLC, a biopharmaceutical company targeting neuropsychiatric disorders. With experience at companies like Ameridose, Sperian Protection, and RecoveryCare, Paul has a strong background in finance and leadership. Paul also worked as a Finance Manager at Johnson & Johnson's DePuy Synthes division. Paul holds an MBA and a BS in Finance from Bryant University.